Can One Alcohol Binge Change Neutrophils Without Detectable Gut Leakage?

Short answer: No. One drinking episode does not necessarily produce a measurable increase in intestinal permeability. In a 2019 observational pilot study, 15 healthy adults consumed a standardized vodka dose. Researchers detected short-lived changes in laboratory neutrophil responses, but did not detect statistically significant changes in the measured gut-permeability indices, circulating bacterial-product markers, or stool-microbiome profiles within their observation windows. This does not prove that alcohol can never alter intestinal permeability—or that a negative test definitively excludes microscopic injury in an individual.

The source is Stadlbauer and colleagues’ complete original PLOS ONE human study, doi:10.1371/journal.pone.0211703. Its most useful forensic lesson concerns what was measured, when it was measured, and which inference the measurements actually support. A blood ethanol result, urinary sugar-probe index, stool-sequencing profile and laboratory neutrophil response are four different types of evidence.

What did the 15-person human study actually test?

The investigators enrolled 15 young, apparently healthy adult volunteers in a single-arm observational pilot. There were 11 men and four women; the mean reported age was 26 years. After overnight fasting, each participant consumed 2 mL of 40% vodka per kilogram of body weight, mixed with juice to make a 300-mL drink, within 30 minutes. This was a specific research exposure, not a reconstruction of what an unrelated person drank at a party, restaurant or before an accident.

Venous samples were collected before intake and hourly for four hours after the first sip. Intestinal-permeability sugar tests and stool collection were performed the day before and on the day after the exposure. Investigators used blood- and stool-based markers and sequenced bacterial DNA from stool. Because everyone received the alcohol exposure, there was no concurrent randomized alcohol-free control arm. The project was exploratory, and the authors did not perform a formal prospective sample-size calculation.

Those design choices matter to causation. Repeated measurements can reveal change over time, but without a parallel nondrinking group they do not isolate every potential influence of fasting, circadian timing, testing variability or study conditions. Fifteen subjects also cannot provide a reliable clinical rule for every sex, age, disease state, drinking pattern or co-exposure.

Which result was negative—and which immune measurements changed?

The study’s central contrast is easy to misstate. Neutrophil assay responses changed; the investigators did not observe corresponding group-level changes in their tested intestinal barrier, blood bacterial-product, inflammation or stool-community endpoints. These findings are not contradictory, because they measure different biological compartments and mechanisms.

The paper presents group comparisons and figure-level significance markers, not a validated individual diagnostic threshold. It reported significant neutrophil priming at one hour, E. coli-stimulated oxidative burst at two hours, and the percentage of non-phagocytosing neutrophils at three hours. A transient laboratory finding does not become a durable organ injury merely because it reaches a conventional p-value.

How do urine sugar probes differ from a blood alcohol result?

Urine sugar-probe testing asks what proportion of orally supplied molecules is subsequently recovered after crossing the gastrointestinal barrier. The study used a lactulose/mannitol/sucrose challenge and analyzed urinary recovery using nuclear magnetic resonance spectroscopy. Its results depend on the administered probe, sampling interval, renal handling and the mathematical comparison chosen. It is not an ethanol test.

A blood ethanol assay, by contrast, aims to quantify the analyte ethanol in a particular specimen collected at a particular time. The study reports an alcohol concentration trajectory that peaked about an hour after intake, but its article does not provide a basis for treating every blood-related graph value as a standardized forensic headspace-GC whole-blood BAC determination. A separate forensic investigation would require the actual collection record, matrix, analytical method, calibration, quality controls and reporting convention.

There is no validated equation in this study by which a person’s BAC can be converted into their intestinal lactulose/mannitol ratio. Conversely, a negative urinary permeability test cannot prove the absence of ethanol exposure, calculate ethanol clearance, or establish driving competence. For basic distinctions in specimen and method interpretation, see specimen collection in forensic toxicology and blood alcohol analysis by headspace chromatography.

Does an unchanged gut-permeability measurement prove the gut was unaffected?

No: failure to detect a difference is not proof of equivalence. An experiment designed and powered to demonstrate equivalence needs prespecified margins and enough observations to exclude clinically meaningful differences. This pilot was not that kind of study. An absence of statistical significance is compatible with no effect, a modest effect obscured by variability, or a biological effect missed because of the chosen timing, assay or population.

The serum measurements covered a short four-hour window. The stool and urinary comparisons were made on adjacent days. If a biological response were brief, compartment-specific or delayed, that schedule might miss it. If an outcome changes below the assay’s sensitivity or in only a small subgroup, an average from 15 healthy subjects may not reveal it. None of those possibilities is proof that such a change actually occurred; they are reasons not to convert a negative result into an absolute proposition.

In a dispute over alleged gastrointestinal injury, the scientifically appropriate question is not whether a paper contains the phrase “no change.” It is whether the same matrix, analyte, biological process, timing, clinical population and claimed injury were examined with sufficient precision to bear on the specific assertion. The answer may be limited.

What did the investigators measure in the gut microbiome?

Stool bacterial-community profiles were generated using 16S ribosomal DNA sequencing. That method describes which bacterial sequence groups are represented in a specimen at the resolution and biases of the assay. The investigators compared measures of within-sample diversity (alpha diversity), between-sample differences (beta diversity), and bacterial taxonomic abundances. They found no detectable change across their sampling interval.

The paper also used PICRUSt, a bioinformatics method that predicts likely microbial gene functions from the observed 16S sequence profiles and reference databases. This is a model-derived pathway estimate, not a direct measurement of microbial gene expression, toxin production, metabolite flux or actual clinical infection. Its failure to show a difference cannot establish that every metabolic function of every organism stayed unchanged.

Forensic writing should preserve those layers. “Stool community composition did not change significantly” is narrower than “the microbiome was unaffected.” “Predicted pathway profiles were unchanged” is narrower still than an assertion that all bacterial biochemical behavior was identical before and after ethanol.

Why did immune-cell responses move when gut markers did not?

The researchers evaluated blood neutrophils outside the body using different laboratory stimuli. Some cells were exposed to fMLP to evaluate priming; others to labeled E. coli or oxidative-burst stimulation. Flow cytometry recorded fluorescence-related responses in selected cell populations. These assays address the cells’ behavior under the assay conditions, not whether an individual developed a bacterial infection in daily life.

A higher fraction of cells generating a reactive oxygen species signal can coexist with a small rise in cells that fail a phagocytosis threshold. Immune activity is multidimensional. It is a mistake to collapse those results into “alcohol strengthens the immune system” or “alcohol causes infection.” More oxidative activity is not a blanket measure of effective bacterial killing; reduced uptake by some cells is not proof a patient will develop sepsis.

In the original paper the authors described changes as transient and mild, and explicitly could not connect the assay findings to actual infection outcomes. A litigation expert should therefore distinguish observed ex-vivo cellular response from clinical susceptibility and from the much narrower question of whether alcohol caused a particular patient’s pneumonia, wound infection or other outcome.

What is the forensic significance of differing matrices and timepoints?

When laboratory studies test blood, serum, urine and stool, the results are neither redundant nor interchangeable. Each has its own biological and preanalytic clock. Venous blood reflects a circulating compartment at the moment of collection. Urine sugar recovery integrates a period after challenge and is affected by test protocol. Stool 16S sequencing depicts a collected community sample rather than a continuous real-time picture. Ex-vivo assays add reagents and stimulation conditions after collection.

That is why a measured ethanol concentration cannot be treated as a direct measure of gut barrier integrity, inflammatory signaling, or cellular phagocytosis. Nor do microbiome profiles or immune-cell fluorescence quantify behavioral performance. For the separate principles governing dose, distribution and concentration-time interpretation, see this site’s pharmacokinetics and toxicology guide.

What are the study’s material limitations?

The design was small, observational and nonrandomized, without a concurrent nondrinking control group. Participants were comparatively young and healthy. A standardized dose of vodka in juice after fasting may not reproduce habitual drinking, repeated binges, mixing alcohol with food or drugs, underlying liver disease, inflammatory bowel disease, immunosuppression or other substantial health conditions.

The authors did not establish precise clinical thresholds for a positive gut-permeability diagnosis, nor did they follow actual infection rates or validate an individual’s crash, occupational error, driving behavior or forensic impairment. The study’s null gut findings should also be read alongside its own acknowledgment that other research using different populations and protocols has produced different results. This article draws its scientific claims from the Stadlbauer primary study alone; it does not assign another study’s results to this experiment.

Nothing in the source supports a definitive proposition that one binge always causes or never causes intestinal damage. The legitimate conclusion is specific to the assays, healthy volunteers, observation windows and statistical resolution in this pilot.

Frequently asked questions

Does one binge drinking episode necessarily cause “leaky gut”?

No universal conclusion follows. This 15-person study did not detect a group-level increase in the measured barrier indices after its particular vodka exposure. That is not a validated exclusion test for every person or every possible post-exposure time.

Did the study prove there was no bacterial translocation?

No. Serum bacterial-product markers did not show an increase in the investigators’ four-hour observation period. Non-detection under a defined assay is different from proving that bacterial products never crossed any barrier at any time.

Did the stool microbiome change after drinking?

No statistically significant change was detected in the tested community composition or model-predicted functions from the before/next-day samples. Short-term sampling and 16S resolution restrict the claim.

Does a rise in neutrophil reactive oxygen species mean stronger immunity?

Not necessarily. The stimulated laboratory response increased transiently, while a small percentage more neutrophils failed the phagocytosis assay threshold. The study did not measure clinical infection resistance.

Can a blood alcohol concentration predict a person’s gut permeability?

No validated person-specific BAC-to-permeability mapping came from this study. The analytes, specimens and sampling processes address different questions.

Could this study prove an alcohol-related infection in litigation?

No. It did not measure actual infections, individual susceptibility or an injured person’s causal history. Such an opinion requires direct medical and exposure evidence and a differential-causation analysis.

Does this mean ethanol cannot injure the intestine?

No. A small negative pilot on selected endpoints is not a general biological impossibility finding. It cannot be projected to repeated heavy use, different routes, patients with disease or periods not sampled.

Primary research and scope of the conclusion

Primary paper: Stadlbauer V, Horvath A, Komarova I, et al. A single alcohol binge impacts on neutrophil function without changes in gut barrier function and gut microbiome composition in healthy volunteers. PLOS ONE. 2019;14(2):e0211703. https://doi.org/10.1371/journal.pone.0211703.

Bottom line: An acute drinking exposure was followed by measurable, transient ex-vivo neutrophil responses in this small human pilot, without detected changes in its selected gut barrier, bacterial-product or stool-microbiome measures. That is a careful study-specific inference—not an individual medical diagnosis, a quantified whole-blood impairment rule, or proof of clinical/legal causation.